Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on ACTAVIS INC
09/29DJAllergan Reiterates Opposition to Valeant Bid
09/25 ACTAVIS : Confirms Generic Butrans® Patent Challenge
09/24DJDOW INDEX OVERSEERS MAKE IT OFFICIAL : U.S. Firms Only
09/24 ACTAVIS IN BUYOUT TALKS WITH SALIX : Cnbc
09/24DJU.S. HOT STOCKS : Hot Stocks to Watch
09/23 Pfizer approaches Actavis to gauge interest in deal - Bloomberg
09/23DJPfizer Has Contacted Actavis About Potential Deal, Parties Not In Formal Talk..
09/16DJU.S. HOT STOCKS : Hot Stocks to Watch
09/09 ACTAVIS : FDA Advisory Committee Recommends Against Approval of Actavis' Nebivol..
09/05 ACTAVIS : Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, ..
09/02 ACTAVIS : Announces FDA Acceptance for Filing of NDA for Eluxadoline
08/26 ACTAVIS : to Present at Morgan Stanley Global Healthcare Conference 2014
08/22 ACTAVIS : Confirms Generic Neupro® Patent Challenge
08/21DJU.S. Restricts Narcotic Pain Drug Prescriptions
08/21DJDEA Restricts Narcotic Pain Drug Prescriptions
08/21 Pfizer back for AstraZeneca? Year-end move seen most likely
08/19 ACTAVIS : Announces Positive Topline Results From The Phase III Program Of Cefta..
08/05DJU.S. HOT STOCKS : Hot Stocks to Watch
07/30 AstraZeneca buys Almirall lung drugs for up to $2.1 billion
07/28 Pfizer's need for deal looms larger with earnings report
07/21 ACTAVIS : Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for..
07/21 ACTAVIS : Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for..
07/14DJU.S. HOT STOCKS : Hot Stocks to Watch
07/11 ACTAVIS : Confirms Generic Diclegis® Patent Challenge
07/08 ACTAVIS : Confirms Generic Ampyra® Patent Challenge
07/02 ACTAVIS : Impax Acquires Two Products from Actavis
07/02 ACTAVIS : Announces Final Stockholder Merger Consideration Election Results in C..
07/01 ACTAVIS : Completes Forest Laboratories Acquisition
07/01 ACTAVIS : Appoints New Members and Announces Changes to Board of Directors Follo..
07/01 ACTAVIS : Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, A..
06/30 ACTAVIS : and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisitio..
06/30 ACTAVIS : Confirms Generic Zubsolv® Patent Challenge
06/25 Patent win helps Shire as AbbVie plots next bid move
06/24DJAffiliated Managers Group to Join S&P 500
06/24 ACTAVIS : and Forest Announce Tentative Election Deadline of June 27, 2014
06/23DJFOREST LABORATORIES : Labs Posts Positive Results for Anxiety Disorder Drug
06/19 ACTAVIS : Confirms District Court Ruling In Generic Exelon® Patch Patent Suit
06/19DJActavis Generic Exelon Patch Found to Infringe on Patents
06/17 ACTAVIS : and Forest Shareholders Approve Proposals Related to Actavis' Planned ..
06/17 ACTAVIS : and Forest Shareholders Approve Proposals Related to Actavis’ Pl..
06/13DJU.S. HOT STOCKS : Hot Stocks to Watch
06/10 ACTAVIS : Prices $3.7 Billion of Senior Unsecured Notes
06/10 ACTAVIS : Announces Offering of Senior Unsecured Notes
06/09 ACTAVIS : Finalizes Agreement Related to Asacol® HD Patent Challenge Litigation
06/09 ACTAVIS : Extends Expiration Time of Offer to Guarantee Certain Forest Laborator..
06/02DJADR Shares End Mixed
05/30 ACTAVIS : Announces Nuvigil® Patent Challenge Settlement
05/26 A bitter pill as China crackdowns squeeze pharma margins
05/24 A bitter pill as China crackdowns squeeze pharma margins
05/22 ACTAVIS : Offers to Guarantee Certain Forest Laboratories Senior Notes in connec..
05/21 ACTAVIS : to Present at Goldman Sachs 35th Annual Global Healthcare Conference 2..
05/15DJThird Point Adds New Stakes in American Airlines, Anheuser-Busch
05/15DJThird Point Adds New Stakes in American Airlines, Anheuser-Busch
05/15 Eli Lilly loses UK Alimta patent case to Actavis
05/15 ACTAVIS : Extends Exclusive Agreement to Distribute Authorized Generic Concerta®
05/15DJU.S. HOT STOCKS : Hot Stocks to Watch
05/15 ACTAVIS : Eli Lilly loses Alimta patent case to Actavis
05/14DJFOREST LABORATORIES : Labs' Saunders to Head Actavis After Deal
05/12 ACTAVIS : Announces Acanya® Gel Patent Challenge Settlement
05/07 ACTAVIS : Launches Generic Version of Catapres-TTS®
05/06 Factbox - M&A frenzy transforming global pharma
05/06 M&A frenzy in healthcare sector
05/05 ACTAVIS : and Forest Announce Effectiveness of Registration Statement on Form S-..
05/02 EXCLUSIVE : Abbott taps Morgan Stanley to sell mature products - sources
05/01 Pfizer's designs on AstraZeneca stir tax envy among rivals
04/30 ACTAVIS : Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014; Non-..
04/28 Pfizer move to join tax-driven deal-making raises red flags in U.S
04/28 Pfizer move to join tax-driven deal-making raises red flags in U.S
04/28 ACTAVIS : Sues FDA Regarding Delay of Generic Celebrex® Approval
04/24 EXCLUSIVE - ALLERGAN APPROACHED SHIR : sources
04/24DJActavis Settles Celebrex Case With Pfizer -- Update
04/24 ACTAVIS : Announces Celebrex® Patent Challenge Settlement
04/21 ACTAVIS : Announces Departure of G. Frederick Wilkinson, President, Actavis Glob..
04/17 ACTAVIS : and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Ro..
04/14 Investors support deals spree, happy to see U.S. companies buy growth
Prev.1   2  3  4  5  6  7  8  9Next
Advertisement
Dynamic quotes  
ON
| OFF